Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.03 $5.78 Friday, 10th May 2024 BCRX stock ended at $5.32. This is 0.375% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $5.23 to a day high of $5.78.
90 days $4.03 $6.35
52 weeks $4.03 $8.96

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Apr 15, 2020 $2.67 $2.79 $2.55 $2.70 8 373 255
Apr 14, 2020 $2.43 $2.95 $2.36 $2.76 23 545 945
Apr 13, 2020 $2.70 $2.75 $2.24 $2.35 26 775 538
Apr 09, 2020 $2.00 $2.15 $1.99 $2.07 5 776 242
Apr 08, 2020 $1.95 $2.01 $1.94 $2.00 3 885 060
Apr 07, 2020 $2.11 $2.15 $1.91 $1.94 4 793 518
Apr 06, 2020 $2.03 $2.08 $1.97 $2.05 4 586 620
Apr 03, 2020 $1.94 $2.00 $1.88 $1.95 2 934 285
Apr 02, 2020 $1.92 $1.99 $1.80 $1.99 4 205 357
Apr 01, 2020 $1.95 $2.01 $1.82 $1.90 4 495 823
Mar 31, 2020 $1.97 $2.07 $1.93 $2.00 3 976 422
Mar 30, 2020 $2.00 $2.02 $1.90 $1.99 6 052 330
Mar 27, 2020 $1.94 $2.03 $1.91 $1.91 2 603 087
Mar 26, 2020 $2.03 $2.15 $1.92 $1.99 4 452 478
Mar 25, 2020 $2.03 $2.10 $1.95 $2.01 4 145 014
Mar 24, 2020 $2.03 $2.10 $1.89 $2.00 4 305 660
Mar 23, 2020 $1.91 $2.03 $1.78 $1.96 4 233 618
Mar 20, 2020 $2.02 $2.13 $1.75 $1.87 7 822 001
Mar 19, 2020 $1.69 $2.48 $1.66 $1.96 13 091 689
Mar 18, 2020 $1.80 $2.08 $1.58 $1.60 7 231 976
Mar 17, 2020 $1.89 $2.05 $1.75 $1.82 7 092 427
Mar 16, 2020 $2.00 $2.19 $1.75 $1.75 6 132 477
Mar 13, 2020 $2.28 $2.28 $1.86 $2.21 8 181 585
Mar 12, 2020 $2.25 $2.75 $2.02 $2.02 6 783 034
Mar 11, 2020 $2.72 $2.81 $2.29 $2.59 10 136 422
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT